Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.96 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | ANPEP | P15144 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27899777 | 0.98 | ALDH1A1 (0.93) | ALDH1A1LMNAUSP2HSD17B10NPC1 | |
| SCHEMBL9512804 | 0.86 | ALDH1A1 (0.72) | ALDH1A1LMNAUSP2HSD17B10NPC1 | |
| SCHEMBL1174390 | 0.85 | — | — | |
| SCHEMBL14276784 | 0.84 | ALDH1A1 (0.70) | ALDH1A1LMNAUSP2HSD17B10NPC1 | |
| SCHEMBL7979632 | 0.82 | ALDH1A1 (0.68) | ALDH1A1LMNAUSP2HSD17B10NPC1 | |
| SCHEMBL7979638 | 0.82 | ALDH1A1 (0.68) | ALDH1A1LMNAUSP2HSD17B10NPC1 | |
| SCHEMBL23886205 | 0.81 | ALDH1A1 (0.66) | ALDH1A1LMNAMAPTHTTRAB9A | |
| SCHEMBL500486 | 0.81 | ALDH1A1 (0.66) | ALDH1A1LMNAMAPTHTTRAB9A | |
| SCHEMBL23886134 | 0.81 | ALDH1A1 (0.66) | ALDH1A1LMNAMAPTHTTRAB9A | |
| SCHEMBL23886340 | 0.81 | ALDH1A1 (0.66) | ALDH1A1LMNAMAPTHTTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109790146-B | Pharmaceutical compounds | 阿尔麦克探索有限公司 | 2022-08-23 | — | — | CN | disclosed |
| CN-114524721-A | Synthesis process of methacrolein | 郑州中科新兴产业技术研究院 | 2022-05-24 | — | — | CN | disclosed |
| US-9586951-B2 | Morpholine derivative or salt thereof | FUJIFILM CORPORATION (JP) | 2017-03-07 | — | — | US | disclosed |
| US-9586951-B2 | Morpholine derivative or salt thereof | FUJIFILM CORPORATION (JP) | 2017-03-07 | — | — | US | disclosed |
| EP-3042900-A1 | NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF | Fujifilm Corporation (JP) | 2016-07-13 | — | — | EP | disclosed |
| US-20160168139-A1 | NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF | FUJIFILM CORPORATION (JP) | 2016-06-16 | — | — | US | disclosed |
| US-20160168139-A1 | NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF | FUJIFILM CORPORATION (JP) | 2016-06-16 | — | — | US | disclosed |
| WO-2015030057-A1 | NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF | 富士フイルム株式会社 (JP) | 2015-03-05 | — | — | WO | disclosed |
| WO-2012148550-A1 | PRODRUGS OF THERAPEUTIC COMPOUNDS | MYREXIS, INC. (US) | 2012-11-01 | — | — | WO | disclosed |
| US-8105760-B2 | Patterning process and pattern surface coating composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2012-01-31 | — | — | US | disclosed |
| CN-1947066-B | Rinse solution for lithography | TOKYO OHKA KOGYO CO LTD | 2011-04-13 | — | — | CN | disclosed |
| US-20090053657-A1 | PATTERNING PROCESS AND PATTERN SURFACE COATING COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2009-02-26 | — | — | US | disclosed |
| CN-101010640-A | Developing solution composition for lithography and method for resist pattern formation | TOKYO OHKA KOGYO CO LTD (JP) | 2007-08-01 | — | — | CN | disclosed |
| CN-1947066-A | Rinse solution for lithography | TOKYO OHKA KOGYO CO LTD (JP) | 2007-04-11 | — | — | CN | disclosed |
| US-6506939-B1 | Producing N-substituted acrylamides and tertiary amines | CIBA SPECIALTY CHEMICALS WATER TREATMENTS LTD. (GB) | 2003-01-14 | — | — | US | disclosed |
| EP-1140797-A1 | PRODUCTION OF ACRYLIC MONOMERS | Ciba Specialty Chemicals Water Treatments Limited (GB) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000041996-A1 | PRODUCTION OF ACRYLIC MONOMERS | CIBA SPECIALTY CHEMICALS WATER TREATMENTS LIMITED (GB) | 2000-07-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168139-A1 | NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF | PRMT7, RBBP7, RER1 | ALDH1A1 2519/4885LMNA 2540/4885USP2 4202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.